GRI Bio, Inc. logo

GRI Bio, Inc. (GRI) Q3 2024 Earnings

GRI·Reported November 14, 2024·Before market open

Diluted EPS came in at $-11.39, missed the $-0.73 consensus by $10.66.

Diluted EPS
$-11.39missed by $10.66
Consensus: $-0.73
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q3 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q3 2024 Earnings FAQ

Common questions about GRI Bio, Inc.'s Q3 2024 earnings report.

GRI Bio, Inc. (GRI) reported Q3 2024 earnings on November 14, 2024 before market open.

GRI Bio, Inc. reported diluted EPS of $-11.39 for Q3 2024.

EPS missed the consensus estimate of $-0.73 by $10.66.

You can read the 10-Q periodic report (0001824293-24-000105) directly on SEC EDGAR. The filing index links above go to sec.gov.